1. Home
  2. NUVB vs STRA Comparison

NUVB vs STRA Comparison

Compare NUVB & STRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvation Bio Inc.

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$5.73

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Strategic Education Inc.

STRA

Strategic Education Inc.

HOLD

Current Price

$82.93

Market Cap

1.9B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVB
STRA
Founded
2018
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
NUVB
STRA
Price
$5.73
$82.93
Analyst Decision
Strong Buy
Buy
Analyst Count
8
3
Target Price
$11.38
$87.00
AVG Volume (30 Days)
4.6M
191.4K
Earning Date
05-04-2026
04-23-2026
Dividend Yield
N/A
3.04%
EPS Growth
71.56
15.85
EPS
N/A
3.19
Revenue
$62,902,000.00
$997,137,000.00
Revenue This Year
$203.82
$4.71
Revenue Next Year
$58.18
$4.67
P/E Ratio
N/A
$25.60
Revenue Growth
698.96
57.23
52 Week Low
$3.00
$69.70
52 Week High
$9.75
$89.73

Technical Indicators

Market Signals
Indicator
NUVB
STRA
Relative Strength Index (RSI) 37.92 51.61
Support Level $5.28 $77.33
Resistance Level $6.25 $85.00
Average True Range (ATR) 0.29 2.14
MACD -0.12 -0.28
Stochastic Oscillator 12.06 41.34

Price Performance

Historical Comparison
NUVB
STRA

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

Share on Social Networks: